Reactive astrocytes are an important therapeutic target of ALS29, and the microenvironmental signal of the ALS mice spinal cord may differentiate Muse cells into GFAP-positive astrocytes, especially into A2 astrocytes, which might secrete molecules that provide neurotrophic support and modulate inflammatory responses30. The gene discussed is GFAP; the disease is amyotrophic lateral sclerosis.